Cardium InnerCool Therapies San Diego-based San Diego-based medical technology company in the emerging field of patient temperature modulation therapy rapidly and controllably cool the body, cell death cell death and damage caused by acute ischemic events such as heart attack or stroke, and to potentially lessen or prevent associated injuries such as adverse neurological outcomes. For more information about InnerCool subsidiary Cardium including InnerCool the Rapid Blue and Cool Blue patient temperature modulation systems, please visit.
Rapid cooling will particularly important for the conservation of tissue and organ function under conditions of acute ischemia that. From reduced blood flow to critical tissues and organs.
About CardiumCardium Therapeutics, and its subsidiaries, InnerCool Therapies, and the Tissue Repair Company, the medical device company primarily in the development, manufacture and sale of innovative therapeutic agent products and devices for cardiovascular focused, ischemic and related indications. Cardium’s main product candidate Generx is a DNA-based growth factor therapeutic for potential use by interventional cardiologists to promote as a single treatment , and stimulate the growth of collateral circulation in the hearts of patients with developed pectoris, ischemic diseases such as recurrent angina..Findings of a study in Australia at this week’s issue of The Lancet provide soothing of safety of repeated ultrasound scan during pregnancy. 10 years ago of a randomized trial stressed the repeats ultrasound exposure with 5 different times pregnancy to grow restrictions among newborns exposed kids as compared with just an ultrasound exam in utero connected.
Contact: Professor John P Newnham school of Women’s and small children health care, Toronto Memorial Hospital, 374 Bagot Road, Subiaco 6008.